officialstreetpreachers Subscribe
Published: June 30, 2023

Will fetal surgery advancements reframe the abortion debate in favor of pro-lifers?

By The Editor

Fri Jun 30, 2023 – 9:11 pm EDT

(LifeSiteNews) — A groundbreaking first of its kind fetal surgerical clinical trial approved by the FDA saved the life of a baby girl in utero. A routine ultrasound discovered that a Louisiana baby in the womb (Denver Coleman, daughter of Derek and Kenyatta Coleman) had brain abnormalities and an enlarged heart, leading to a medical diagnosis of a “vein of Galen malformation.”

When the blood vessel carrying blood from the brain to the heart does so without first going through capillaries, the unborn child suffers dangerously high blood pressure, creating a risk of heart disease, brain damage, and/or organ failure. Babies born with this condition often don’t survive birth or, if they do, the odds for death prior to their teenage years are 30% to 40%.

Prior to this operation, doctors were only able to try and treat the condition after childbirth. However, little Denver’s case was so severe that doctors gave her a 1% chance of actually surviving to childbirth. Given the critical nature of her ailment, her doctors and parents struggled to find an answer. It was provided by doctors at Boston Children’s Hospital’s Cerebrovascular Surgery

The remainder of this article is available in its entirety at LifeSite News

The views expressed in this news alert by the author do not directly represent that of The Official Street Preachers or its editors


Share this Article

Download the Mobile App.
Exit mobile version